Role of Endothelial Progenitor Cells in Frailty
Abstract
:1. Introduction
1.1. Main Characteristics of EPCs
Isolation, Culturing and Measurement of Human EPCs
1.2. Frailty Models and Epidemiology
2. Impairment of Endothelial Function in Frailty
3. EPCs Response to Endothelial Dysfunction in Frailty
4. EPCs Dysfunction and Frailty Domains
5. Interventions That May Restore EPCs Functioning in Frailty
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- United Nations Department of Economic and Social Affairs Population Division. World Population Ageing 2020 Highlights: Living Arrangements of Older Persons; (ST/ESA/SER.A/451); United Nations: New York, NY, USA, 2020. [Google Scholar]
- United Nations Department of Economic and Social Affairs Population Division. World Population Ageing 2019: Highlights; (ST/ESA/SER.A/430); United Nations: New York, NY, USA, 2019. [Google Scholar]
- Clegg, A.; Young, J.; Iliffe, S.; Rikkert, M.O.; Rockwood, K. Frailty in elderly people. Lancet 2013, 381, 752–762. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cicutto, L.C. Frailty: Is This a New Vital Sign? Chest 2018, 154, 1–2. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chong, E.; Ho, E.; Baldevarona-Llego, J.; Chan, M.; Wu, L.; Tay, L. Frailty and Risk of Adverse Outcomes in Hospitalized Older Adults: A Comparison of Different Frailty Measures. J. Am. Med. Dir. Assoc. 2017, 18, 638e7–638e11. [Google Scholar] [CrossRef] [PubMed]
- Balestroni, G.; Panzeri, A.; Omarini, P.; Cerutti, P.; Sacco, D.; Giordano, A.; Pistono, M.; Komici, K.; Rossi Ferrario, S. Psychophysical health of elderly inpatients in cardiac rehabilitation: A retrospective cohort study. Eur. J. Phys. Rehabil. Med. 2020, 56, 197–205. [Google Scholar] [CrossRef]
- Fried, L.P.; Tangen, C.M.; Walston, J.; Newman, A.B.; Hirsch, C.; Gottdiener, J.; Seeman, T.; Tracy, R.; Kop, W.J.; Burke, G.; et al. Frailty in older adults: Evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci. 2001, 56, M146–M156. [Google Scholar] [CrossRef]
- Komici, K.; Bencivenga, L.; Navani, N.; D’Agnano, V.; Guerra, G.; Bianco, A.; Rengo, G.; Perrotta, F. Frailty in Patients With Lung Cancer: A Systematic Review and Meta-Analysis. Chest 2022, 162, 485–497. [Google Scholar] [CrossRef]
- Hoogendijk, E.O.; Afilalo, J.; Ensrud, K.E.; Kowal, P.; Onder, G.; Fried, L.P. Frailty: Implications for clinical practice and public health. Lancet 2019, 394, 1365–1375. [Google Scholar] [CrossRef]
- Leng, S.X.; Xue, Q.L.; Tian, J.; Walston, J.D.; Fried, L.P. Inflammation and frailty in older women. J. Am. Geriatr. Soc. 2007, 55, 864–871. [Google Scholar] [CrossRef]
- Hubbard, R.E.; O’Mahony, M.S.; Savva, G.M.; Calver, B.L.; Woodhouse, K.W. Inflammation and frailty measures in older people. J. Cell Mol. Med. 2009, 13, 3103–3109. [Google Scholar] [CrossRef] [Green Version]
- Barzilay, J.I.; Blaum, C.; Moore, T.; Xue, Q.L.; Hirsch, C.H.; Walston, J.D.; Fried, L.P. Insulin resistance and inflammation as precursors of frailty: The Cardiovascular Health Study. Arch. Intern. Med. 2007, 167, 635–641. [Google Scholar] [CrossRef] [PubMed]
- Miller, R.A. The aging immune system: Primer and prospectus. Science 1996, 273, 70–74. [Google Scholar] [CrossRef] [PubMed]
- Gimbrone, M.A., Jr.; Garcia-Cardena, G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ. Res. 2016, 118, 620–636. [Google Scholar] [CrossRef] [Green Version]
- Madonna, R.; Novo, G.; Balistreri, C.R. Cellular and molecular basis of the imbalance between vascular damage and repair in ageing and age-related diseases: As biomarkers and targets for new treatments. Mech. Ageing Dev. 2016, 159, 22–30. [Google Scholar] [CrossRef] [PubMed]
- Amarasekera, A.T.; Chang, D.; Schwarz, P.; Tan, T.C. Does vascular endothelial dysfunction play a role in physical frailty and sarcopenia? A systematic review. Age Ageing 2021, 50, 725–732. [Google Scholar] [CrossRef]
- Yang, J.X.; Pan, Y.Y.; Wang, X.X.; Qiu, Y.G.; Mao, W. Endothelial progenitor cells in age-related vascular remodeling. Cell Transplant. 2018, 27, 786–795. [Google Scholar] [CrossRef] [PubMed]
- Yamanashi, H.; Shimizu, Y.; Koyamatsu, J.; Nagayoshi, M.; Kadota, K.; Tamai, M.; Maeda, T. Circulating CD34-Positive Cells Are Associated with Handgrip Strength in Japanese Older Men: The Nagasaki Islands Study. J. Frailty Aging 2017, 6, 6–11. [Google Scholar]
- Qiu, Y.; Zhang, C.; Zhang, G.; Tao, J. Endothelial progenitor cells in cardiovascular diseases. Aging Med. 2018, 1, 204–208. [Google Scholar] [CrossRef] [Green Version]
- Perrotta, F.; Perna, A.; Komici, K.; Nigro, E.; Mollica, M.; D’Agnano, V.; De Luca, A.; Guerra, G. The State of Art of Regenerative Therapy in Cardiovascular Ischemic Disease: Biology, Signaling Pathways, and Epigenetics of Endothelial Progenitor Cells. Cells 2020, 9, 1886. [Google Scholar] [CrossRef]
- Hu, L.; Dai, S.C.; Luan, X.; Chen, J.; Cannavicci, A. Dysfunction and Therapeutic Potential of Endothelial Progenitor Cells in Diabetes Mellitus. J. Clin. Med. Res. 2018, 10, 752–757. [Google Scholar] [CrossRef] [Green Version]
- Komici, K.; Perna, A.; Rocca, A.; Bencivenga, L.; Rengo, G.; Guerra, G. Endothelial Progenitor Cells and Rheumatoid Arthritis: Response to Endothelial Dysfunction and Clinical Evidences. Int. J. Mol. Sci. 2021, 22, 13675. [Google Scholar] [CrossRef]
- Custodia, A.; Ouro, A.; Romaus-Sanjurjo, D.; Pias-Peleteiro, J.M.; de Vries, H.E.; Castillo, J.; Sobrino, T. Endothelial Progenitor Cells and Vascular Alterations in Alzheimer’s Disease. Front Aging Neurosci. 2021, 13, 811210. [Google Scholar] [CrossRef]
- Hristov, M.; Weber, C. Endothelial progenitor cells in vascular repair and remodeling. Pharmacol. Res. 2008, 58, 148–151. [Google Scholar] [CrossRef] [PubMed]
- Asahara, T.; Kawamoto, A.; Masuda, H. Concise review: Circulating endothelial progenitor cells for vascular medicine. Stem Cells 2011, 29, 1650–1655. [Google Scholar] [CrossRef] [PubMed]
- Asahara, T.; Takahashi, T.; Masuda, H.; Kalka, C.; Chen, D.; Iwaguro, H.; Inai, Y.; Silver, M.; Isner, J.M. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999, 18, 3964–3972. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Aicher, A.; Heeschen, C.; Mildner-Rihm, C.; Urbich, C.; Ihling, C.; Technau-Ihling, K.; Zeiher, A.M.; Dimmeler, S. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med. 2003, 9, 1370–1376. [Google Scholar] [CrossRef] [PubMed]
- Medina, R.J.; Barber, C.L.; Sabatier, F.; Dignat-George, F.; Melero-Martin, J.M.; Khosrotehrani, K.; Ohneda, O.; Randi, A.M.; Chan, J.K.Y.; Yamaguchi, T.; et al. Endothelial Progenitors: A Consensus Statement on Nomenclature. Stem Cells Transl. Med. 2017, 6, 1316–1320. [Google Scholar] [CrossRef] [PubMed]
- Lin, R.Z.; Moreno-Luna, R.; Li, D.; Jaminet, S.C.; Greene, A.K.; Melero-Martin, J.M. Human endothelial colony-forming cells serve as trophic mediators for mesenchymal stem cell engraftment via paracrine signaling. Proc. Natl. Acad. Sci. USA 2014, 111, 10137–10142. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Moccia, F.; Negri, S.; Shekha, M.; Faris, P.; Guerra, G. Endothelial Ca(2+) Signaling, Angiogenesis and Vasculogenesis: Just What It Takes to Make a Blood Vessel. Int. J. Mol. Sci. 2019, 20, 3962. [Google Scholar] [CrossRef] [Green Version]
- de Nigris, F.; Balestrieri, M.L.; Williams-Ignarro, S.; D’Armiento, F.P.; Lerman, L.O.; Byrns, R.; Crimi, E.; Palagiano, A.; Fatigati, G.; Ignarro, L.J.; et al. Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways. J. Cardiovasc. Pharmacol. 2007, 50, 424–433. [Google Scholar] [CrossRef] [PubMed]
- Walter, D.H.; Rittig, K.; Bahlmann, F.H.; Kirchmair, R.; Silver, M.; Murayama, T.; Nishimura, H.; Losordo, D.W.; Asahara, T.; Isner, J.M. Statin therapy accelerates reendothelialization: A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002, 105, 3017–3024. [Google Scholar] [CrossRef] [Green Version]
- Yoon, C.H.; Hur, J.; Oh, I.Y.; Park, K.W.; Kim, T.Y.; Shin, J.H.; Kim, J.H.; Lee, C.S.; Chung, J.K.; Park, Y.B.; et al. Intercellular adhesion molecule-1 is upregulated in ischemic muscle, which mediates trafficking of endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 1066–1072. [Google Scholar] [CrossRef] [PubMed]
- Hookham, M.B.; Ali, I.H.; O’Neill, C.L.; Hackett, E.; Lambe, M.H.; Schmidt, T.; Medina, R.J.; Chamney, S.; Rao, B.; McLoone, E.; et al. Hypoxia-induced responses by endothelial colony-forming cells are modulated by placental growth factor. Stem Cell Res. Ther. 2016, 7, 173. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rehman, J.; Li, J.; Orschell, C.M.; March, K.L. Peripheral blood „endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003, 107, 1164–1169. [Google Scholar] [CrossRef] [Green Version]
- Wang, L.; Wang, X.; Xie, G.; Wang, L.; Hill, C.K.; DeLeve, L.D. Liver sinusoidal endothelial cell progenitor cells promote liver regeneration in rats. J. Clin. Investig. 2012, 122, 1567–1573. [Google Scholar] [CrossRef]
- Miyamoto, Y.; Suyama, T.; Yashita, T.; Akimaru, H.; Kurata, H. Bone marrow subpopulations contain distinct types of endothelial progenitor cells and angiogenic cytokine-producing cells. J. Mol. Cell Cardiol. 2007, 43, 627–635. [Google Scholar] [CrossRef] [PubMed]
- Ii, M.; Nishimura, H.; Iwakura, A.; Wecker, A.; Eaton, E.; Asahara, T.; Losordo, D.W. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via “imported” nitric oxide synthase activity. Circulation 2005, 111, 1114–1120. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Collett, J.A.; Mehrotra, P.; Crone, A.; Shelley, W.C.; Yoder, M.C.; Basile, D.P. Endothelial colony-forming cells ameliorate endothelial dysfunction via secreted factors following ischemia-reperfusion injury. Am. J. Physiol. Renal. Physiol. 2017, 312, F897–F907. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Naito, H.; Kidoya, H.; Sakimoto, S.; Wakabayashi, T.; Takakura, N. Identification and characterization of a resident vascular stem/progenitor cell population in preexisting blood vessels. EMBO J. 2012, 31, 842–855. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kang, K.T.; Coggins, M.; Xiao, C.; Rosenzweig, A.; Bischoff, J. Human vasculogenic cells form functional blood vessels and mitigate adverse remodeling after ischemia reperfusion injury in rats. Angiogenesis 2013, 16, 773–784. [Google Scholar] [CrossRef] [Green Version]
- Ding, J.; Zhao, Z.; Wang, C.; Wang, C.X.; Li, P.C.; Qian, C.; Teng, G.J. Bioluminescence imaging of transplanted human endothelial colony-forming cells in an ischemic mouse model. Brain Res. 2016, 1642, 209–218. [Google Scholar] [CrossRef]
- Kang, K.T.; Lin, R.Z.; Kuppermann, D.; Melero-Martin, J.M.; Bischoff, J. Endothelial colony forming cells and mesenchymal progenitor cells form blood vessels and increase blood flow in ischemic muscle. Sci. Rep. 2017, 7, 770. [Google Scholar] [CrossRef] [PubMed]
- Forte, A.; Della Corte, A.; De Feo, M.; Cerasuolo, F.; Cipollaro, M. Role of myofibroblasts in vascular remodelling: Focus on restenosis and aneurysm. Cardiovasc. Res. 2010, 88, 395–405. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Scheubel, R.J.; Zorn, H.; Silber, R.E.; Kuss, O.; Morawietz, H.; Holtz, J.; Simm, A. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J. Am. Coll. Cardiol. 2003, 42, 2073–2080. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zeng, L.; Zhang, C.; Cai, G.; Zhang, B.; Huang, Z.; Wu, M.; Zhu, Y.; Luo, L.; He, H.; Yang, Z. Aging-Related Endothelial Progenitor Cell Dysfunction and Its Association with IL-17 and IL-23 in HFmrEF Patients. Oxid. Med. Cell Longev. 2022, 2022, 2281870. [Google Scholar] [CrossRef] [PubMed]
- Zeng, L.; Zhang, C.; Zhu, Y.; Liu, Z.; Liu, G.; Zhang, B.; Tu, C.; Yang, Z. Hypofunction of Circulating Endothelial Progenitor Cells and Aggravated Severity in Elderly Male Patients With Non-ST Segment Elevation Myocardial Infarction: Its Association With Systemic Inflammation. Front. Cardiovasc. Med. 2021, 8, 687590. [Google Scholar] [CrossRef]
- Shao, H.; Xu, Q.; Wu, Q.; Ma, Q.; Salgueiro, L.; Wang, J.; Eton, D.; Webster, K.A.; Yu, H. Defective CXCR4 expression in aged bone marrow cells impairs vascular regeneration. J. Cell Mol. Med. 2011, 15, 2046–2056. [Google Scholar] [CrossRef]
- Xu, Q.; Wang, J.; He, J.; Zhou, M.; Adi, J.; Webster, K.A.; Yu, H. Impaired CXCR4 expression and cell engraftment of bone marrow-derived cells from aged atherogenic mice. Atherosclerosis 2011, 219, 92–99. [Google Scholar] [CrossRef] [Green Version]
- Xia, W.H.; Li, J.; Su, C.; Yang, Z.; Chen, L.; Wu, F.; Zhang, Y.Y.; Yu, B.B.; Qiu, Y.X.; Wang, S.M.; et al. Physical exercise attenuates age-associated reduction in endothelium-reparative capacity of endothelial progenitor cells by increasing CXCR4/JAK-2 signaling in healthy men. Aging Cell 2012, 11, 111–119. [Google Scholar] [CrossRef]
- Hirschi, K.K.; Ingram, D.A.; Yoder, M.C. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 1584–1595. [Google Scholar] [CrossRef] [Green Version]
- Moccia, F.; Zuccolo, E.; Poletto, V.; Cinelli, M.; Bonetti, E.; Guerra, G.; Rosti, V. Endothelial progenitor cells support tumour growth and metastatisation: Implications for the resistance to anti-angiogenic therapy. Tumour. Biol. 2015, 36, 6603–6614. [Google Scholar] [CrossRef]
- Khan, S.S.; Solomon, M.A.; McCoy, J.P., Jr. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin. Cytom. 2005, 64, 1–8. [Google Scholar] [CrossRef] [PubMed]
- Peichev, M.; Naiyer, A.J.; Pereira, D.; Zhu, Z.; Lane, W.J.; Williams, M.; Oz, M.C.; Hicklin, D.J.; Witte, L.; Moore, M.A.; et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000, 95, 952–958. [Google Scholar] [CrossRef] [PubMed]
- Gehling, U.M.; Ergun, S.; Schumacher, U.; Wagener, C.; Pantel, K.; Otte, M.; Schuch, G.; Schafhausen, P.; Mende, T.; Kilic, N.; et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000, 95, 3106–3112. [Google Scholar] [CrossRef]
- Case, J.; Mead, L.E.; Bessler, W.K.; Prater, D.; White, H.A.; Saadatzadeh, M.R.; Bhavsar, J.R.; Yoder, M.C.; Haneline, L.S.; Ingram, D.A. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp. Hematol. 2007, 35, 1109–1118. [Google Scholar] [CrossRef] [PubMed]
- Timmermans, F.; Van Hauwermeiren, F.; De Smedt, M.; Raedt, R.; Plasschaert, F.; De Buyzere, M.L.; Gillebert, T.C.; Plum, J.; Vandekerckhove, B. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 1572–1579. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Asahara, T.; Murohara, T.; Sullivan, A.; Silver, M.; van der Zee, R.; Li, T.; Witzenbichler, B.; Schatteman, G.; Isner, J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275, 964–967. [Google Scholar] [CrossRef] [PubMed]
- Ito, H.; Rovira, I.I.; Bloom, M.L.; Takeda, K.; Ferrans, V.J.; Quyyumi, A.A.; Finkel, T. Endothelial progenitor cells as putative targets for angiostatin. Cancer Res. 1999, 59, 5875–5877. [Google Scholar]
- Hill, J.M.; Zalos, G.; Halcox, J.P.; Schenke, W.H.; Waclawiw, M.A.; Quyyumi, A.A.; Finkel, T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 2003, 348, 593–600. [Google Scholar] [CrossRef]
- Yoder, M.C.; Mead, L.E.; Prater, D.; Krier, T.R.; Mroueh, K.N.; Li, F.; Krasich, R.; Temm, C.J.; Prchal, J.T.; Ingram, D.A. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007, 109, 1801–1809. [Google Scholar] [CrossRef] [Green Version]
- Rohde, E.; Malischnik, C.; Thaler, D.; Maierhofer, T.; Linkesch, W.; Lanzer, G.; Guelly, C.; Strunk, D. Blood monocytes mimic endothelial progenitor cells. Stem Cells 2006, 24, 357–367. [Google Scholar] [CrossRef]
- Kalka, C.; Masuda, H.; Takahashi, T.; Kalka-Moll, W.M.; Silver, M.; Kearney, M.; Li, T.; Isner, J.M.; Asahara, T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA 2000, 97, 3422–3427. [Google Scholar] [CrossRef]
- Lin, Y.; Weisdorf, D.J.; Solovey, A.; Hebbel, R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Investig. 2000, 105, 71–77. [Google Scholar] [CrossRef] [PubMed]
- Rothman, M.D.; Leo-Summers, L.; Gill, T.M. Prognostic significance of potential frailty criteria. J. Am. Geriatr. Soc. 2008, 56, 2211–2216. [Google Scholar] [CrossRef] [Green Version]
- Mitnitski, A.B.; Mogilner, A.J.; Rockwood, K. Accumulation of deficits as a proxy measure of aging. Sci. World J. 2001, 1, 323–336. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rockwood, K.; Mitnitski, A.; Song, X.; Steen, B.; Skoog, I. Long-term risks of death and institutionalization of elderly people in relation to deficit accumulation at age 70. J. Am. Geriatr. Soc. 2006, 54, 975–979. [Google Scholar] [CrossRef] [PubMed]
- Song, X.; Mitnitski, A.; Rockwood, K. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J. Am. Geriatr. Soc. 2010, 58, 681–687. [Google Scholar] [CrossRef] [Green Version]
- Sutton, J.L.; Gould, R.L.; Daley, S.; Coulson, M.C.; Ward, E.V.; Butler, A.M.; Nunn, S.P.; Howard, R.J. Psychometric properties of multicomponent tools designed to assess frailty in older adults: A systematic review. BMC Geriatr. 2016, 16, 55. [Google Scholar] [CrossRef] [Green Version]
- Jones, D.; Song, X.; Mitnitski, A.; Rockwood, K. Evaluation of a frailty index based on a comprehensive geriatric assessment in a population based study of elderly Canadians. Aging Clin. Exp. Res. 2005, 17, 465–471. [Google Scholar] [CrossRef]
- Nishijima, T.F.; Shimokawa, M.; Esaki, T.; Morita, M.; Toh, Y.; Muss, H.B. A 10-Item Frailty Index Based on a Comprehensive Geriatric Assessment (FI-CGA-10) in Older Adults with Cancer: Development and Construct Validation. Oncologist 2021, 26, e1751–e1760. [Google Scholar] [CrossRef]
- Komici, K.; Cappuccio, M.; Scacchi, A.; Vaschetti, R.; Delli Carpini, G.; Picerno, V.; Avella, P.; Brunese, M.C.; Rengo, G.; Guerra, G.; et al. The Prevalence and the Impact of Frailty in Hepato-Biliary Pancreatic Cancers: A Systematic Review and Meta-Analysis. J. Clin. Med. 2022, 11, 1116. [Google Scholar] [CrossRef]
- Ensrud, K.E.; Ewing, S.K.; Cawthon, P.M.; Fink, H.A.; Taylor, B.C.; Cauley, J.A.; Dam, T.T.; Marshall, L.M.; Orwoll, E.S.; Cummings, S.R.; et al. A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men. J. Am. Geriatr. Soc. 2009, 57, 492–498. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Metzelthin, S.F.; Daniels, R.; van Rossum, E.; de Witte, L.; van den Heuvel, W.J.; Kempen, G.I. The psychometric properties of three self-report screening instruments for identifying frail older people in the community. BMC Public Health 2010, 10, 176. [Google Scholar] [CrossRef] [PubMed]
- O’Caoimh, R.; Sezgin, D.; O’Donovan, M.R.; Molloy, D.W.; Clegg, A.; Rockwood, K.; Liew, A. Prevalence of frailty in 62 countries across the world: A systematic review and meta-analysis of population-level studies. Age Ageing 2021, 50, 96–104. [Google Scholar] [CrossRef] [PubMed]
- Feng, Z.; Lugtenberg, M.; Franse, C.; Fang, X.; Hu, S.; Jin, C.; Raat, H. Risk factors and protective factors associated with incident or increase of frailty among community-dwelling older adults: A systematic review of longitudinal studies. PLoS ONE 2017, 12, e0178383. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Newman, A.B.; Gottdiener, J.S.; McBurnie, M.A.; Hirsch, C.H.; Kop, W.J.; Tracy, R.; Walston, J.D.; Fried, L.P.; Cardiovascular Health Study Research Group. Associations of subclinical cardiovascular disease with frailty. J. Gerontol. A Biol. Sci. Med. Sci. 2001, 56, M158–M166. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Alonso-Bouzon, C.; Carcaillon, L.; Garcia-Garcia, F.J.; Amor-Andres, M.S.; El Assar, M.; Rodriguez-Manas, L. Association between endothelial dysfunction and frailty: The Toledo Study for Healthy Aging. Age 2014, 36, 495–505. [Google Scholar] [CrossRef] [Green Version]
- Rodriguez-Manas, L.; El-Assar, M.; Vallejo, S.; Lopez-Doriga, P.; Solis, J.; Petidier, R.; Montes, M.; Nevado, J.; Castro, M.; Gomez-Guerrero, C.; et al. Endothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation. Aging Cell 2009, 8, 226–238. [Google Scholar] [CrossRef]
- Obayashi, K.; Saeki, K.; Maegawa, T.; Sakai, T.; Kitagawa, M.; Otaki, N.; Kataoka, H.; Kurumatani, N. Association of Serum Asymmetric Dimethylarginine With Muscle Strength and Gait Speed: A Cross-Sectional Study of the HEIJO-KYO Cohort. J. Bone Miner Res. 2016, 31, 1107–1113. [Google Scholar] [CrossRef] [Green Version]
- Valdiglesias, V.; Marcos-Perez, D.; Lorenzi, M.; Onder, G.; Gostner, J.M.; Strasser, B.; Fuchs, D.; Bonassi, S. Immunological alterations in frail older adults: A cross sectional study. Exp. Gerontol. 2018, 112, 119–126. [Google Scholar] [CrossRef]
- Heffernan, K.S.; Chale, A.; Hau, C.; Cloutier, G.J.; Phillips, E.M.; Warner, P.; Nickerson, H.; Reid, K.F.; Kuvin, J.T.; Fielding, R.A. Systemic vascular function is associated with muscular power in older adults. J. Aging Res. 2012, 2012, 386387. [Google Scholar] [CrossRef] [Green Version]
- Campos, A.M.; Moura, F.A.; Santos, S.N.; Freitas, W.M.; Sposito, A.C.; Brasilia Study on Healthy, A.; Brasilia Heart, S. Sarcopenia, but not excess weight or increased caloric intake, is associated with coronary subclinical atherosclerosis in the very elderly. Atherosclerosis 2017, 258, 138–144. [Google Scholar] [CrossRef] [PubMed]
- Yamanashi, H.; Kulkarni, B.; Edwards, T.; Kinra, S.; Koyamatsu, J.; Nagayoshi, M.; Shimizu, Y.; Maeda, T.; Cox, S.E. Association between atherosclerosis and handgrip strength in non-hypertensive populations in India and Japan. Geriatr. Gerontol. Int. 2018, 18, 1071–1078. [Google Scholar] [CrossRef] [PubMed]
- Santillo, E.M.M.; Balestrini, F. Frailty and flow-mediated dilation: A pilot study in hospitalized elderly. J. Curr. Res. Sci. Med. 2016, 2, 92. [Google Scholar] [CrossRef]
- Mansur, H.N.; Lovisi, J.C.; Colugnati, F.A.; Raposo, N.R.; Fernandes, N.M.; Bastos, M.G. Association of frailty with endothelial dysfunction and its possible impact on negative outcomes in Brazilian predialysis patients with chronic kidney disease. BMC Nephrol. 2015, 16, 157. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, J.S.; Auyeung, T.W.; Leung, J.; Kwok, T.; Leung, P.C.; Woo, J. Physical frailty in older adults is associated with metabolic and atherosclerotic risk factors and cognitive impairment independent of muscle mass. J. Nutr. Health Aging 2011, 15, 857–862. [Google Scholar] [CrossRef]
- Del Brutto, O.H.; Mera, R.M.; Brown, D.L.; Nieves, J.L.; Milla-Martinez, M.F.; Fanning, K.D.; Cagino, K.; Zambrano, M.; Sedler, M.J. The association of frailty with abnormal ankle-brachial index determinations is related to age: Results from the Atahualpa Project. Int. J. Cardiol. 2016, 202, 366–367. [Google Scholar] [CrossRef]
- McKechnie, D.G.J.; Patel, M.; Papacosta, A.O.; Lennon, L.T.; Ellins, E.A.; Halcox, J.P.J.; Ramsay, S.E.; Whincup, P.H.; Wannamethee, S.G. Associations between inflammation, coagulation, cardiac strain and injury, and subclinical vascular disease with frailty in older men: A cross-sectional study. BMC Geriatr. 2022, 22, 405. [Google Scholar] [CrossRef]
- Cole, J.A.; Kehmeier, M.N.; Bedell, B.R.; Krishna Kumaran, S.; Henson, G.D.; Walker, A.E. Sex Differences in the Relation between Frailty and Endothelial Dysfunction in Old Mice. J. Gerontol. A Biol. Sci. Med. Sci. 2022, 77, 416–423. [Google Scholar] [CrossRef]
- Whitehead, J.C.; Hildebrand, B.A.; Sun, M.; Rockwood, M.R.; Rose, R.A.; Rockwood, K.; Howlett, S.E. A clinical frailty index in aging mice: Comparisons with frailty index data in humans. J. Gerontol. A Biol. Sci. Med. Sci. 2014, 69, 621–632. [Google Scholar] [CrossRef]
- Thum, T.; Tsikas, D.; Stein, S.; Schultheiss, M.; Eigenthaler, M.; Anker, S.D.; Poole-Wilson, P.A.; Ertl, G.; Bauersachs, J. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J. Am. Coll. Cardiol. 2005, 46, 1693–1701. [Google Scholar] [CrossRef] [Green Version]
- Goette, A.; Wolfram, O.; Jentsch-Ullrich, K.; Martens-Lobenhoffer, J.; Scalera, F.; Lendeckel, U.; Bode-Boger, S.M. The effects of G-CSF-induced mobilization of progenitor cells are limited by ADMA. Int. J. Cardiol. 2010, 143, 264–270. [Google Scholar] [CrossRef] [PubMed]
- Surdacki, A.; Marewicz, E.; Wieczorek-Surdacka, E.; Rakowski, T.; Szastak, G.; Pryjma, J.; Dudek, D.; Dubiel, J.S. Synergistic effects of asymmetrical dimethyl-L-arginine accumulation and endothelial progenitor cell deficiency on renal function decline during a 2-year follow-up in stable angina. Nephrol. Dial. Transplant. 2010, 25, 2576–2583. [Google Scholar] [CrossRef] [PubMed]
- Ozkok, A.; Aktas, E.; Yilmaz, A.; Telci, A.; Oflaz, H.; Deniz, G.; Yildiz, A. Decrease in endothelial progenitor cells associated with inflammation, but not with endothelial dysfunction in chronic hemodialysis patients. Clin. Nephrol. 2013, 79, 21–30. [Google Scholar] [CrossRef]
- Yuan, Q.; Hu, C.P.; Gong, Z.C.; Bai, Y.P.; Liu, S.Y.; Li, Y.J.; Jiang, J.L. Accelerated onset of senescence of endothelial progenitor cells in patients with type 2 diabetes mellitus: Role of dimethylarginine dimethylaminohydrolase 2 and asymmetric dimethylarginine. Biochem. Biophys. Res. Commun. 2015, 458, 869–876. [Google Scholar] [CrossRef]
- Ye, S.; Zhou, X.; Lin, J.; Chen, P. Asymmetric Dimethylarginine Induced Apoptosis and Dysfunction of Endothelial Progenitor Cells: Role of Endoplasmic Reticulum Stress Pathway. Biomed. Res. Int. 2017, 2017, 6395601. [Google Scholar] [CrossRef]
- Zhang, F.Q.; Lu, W.; Yuan, W.X.; Li, X. Regulation of c-Jun N-Terminal Protein Kinase (JNK) Pathway in Apoptosis of Endothelial Outgrowth Cells Induced by Asymmetric Dimethylarginine. Med. Sci. Monit. 2017, 23, 2535–2542. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Heiss, C.; Schanz, A.; Amabile, N.; Jahn, S.; Chen, Q.; Wong, M.L.; Rassaf, T.; Heinen, Y.; Cortese-Krott, M.; Grossman, W.; et al. Nitric oxide synthase expression and functional response to nitric oxide are both important modulators of circulating angiogenic cell response to angiogenic stimuli. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 2212–2218. [Google Scholar] [CrossRef] [Green Version]
- Liu, Z.; Jiang, Y.; Hao, H.; Gupta, K.; Xu, J.; Chu, L.; McFalls, E.; Zweier, J.; Verfaillie, C.; Bache, R.J. Endothelial nitric oxide synthase is dynamically expressed during bone marrow stem cell differentiation into endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H1760–H1765. [Google Scholar] [CrossRef] [Green Version]
- Sadoun, E.; Reed, M.J. Impaired angiogenesis in aging is associated with alterations in vessel density, matrix composition, inflammatory response, and growth factor expression. J. Histochem. Cytochem. 2003, 51, 1119–1130. [Google Scholar] [CrossRef] [Green Version]
- Li, L.; Liu, H.; Xu, C.; Deng, M.; Song, M.; Yu, X.; Xu, S.; Zhao, X. VEGF promotes endothelial progenitor cell differentiation and vascular repair through connexin 43. Stem Cell Res. Ther. 2017, 8, 237. [Google Scholar] [CrossRef]
- Grunewald, M.; Kumar, S.; Sharife, H.; Volinsky, E.; Gileles-Hillel, A.; Licht, T.; Permyakova, A.; Hinden, L.; Azar, S.; Friedmann, Y.; et al. Counteracting age-related VEGF signaling insufficiency promotes healthy aging and extends life span. Science 2021, 373, 8479. [Google Scholar] [CrossRef] [PubMed]
- Yamamizu, K.; Kawasaki, K.; Katayama, S.; Watabe, T.; Yamashita, J.K. Enhancement of vascular progenitor potential by protein kinase A through dual induction of Flk-1 and Neuropilin-1. Blood 2009, 114, 3707–3716. [Google Scholar] [CrossRef] [PubMed]
- Povsic, T.J.; Sloane, R.; Zhou, J.; Pieper, C.F.; Pearson, M.P.; Peterson, E.D.; Green, J.B.; Cohen, H.J.; Morey, M.C. Lower levels of circulating progenitor cells are associated with low physical function and performance in elderly men with impaired glucose tolerance: A pilot substudy from the VA Enhanced Fitness trial. J. Gerontol. A Biol. Sci. Med. Sci. 2013, 68, 1559–1566. [Google Scholar] [CrossRef]
- Povsic, T.J.; Sloane, R.; Pieper, C.F.; Pearson, M.P.; Peterson, E.D.; Cohen, H.J.; Morey, M.C. Endothelial Progenitor Cell Levels Predict Future Physical Function: An Exploratory Analysis From the VA Enhanced Fitness Study. J. Gerontol. A Biol. Sci. Med. Sci. 2016, 71, 362–369. [Google Scholar] [CrossRef] [Green Version]
- Nation, D.A.; Tan, A.; Dutt, S.; McIntosh, E.C.; Yew, B.; Ho, J.K.; Blanken, A.E.; Jang, J.Y.; Rodgers, K.E.; Gaubert, A. Circulating Progenitor Cells Correlate with Memory, Posterior Cortical Thickness, and Hippocampal Perfusion. J. Alzheimers Dis. 2018, 61, 91–101. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Breining, A.; Silvestre, J.S.; Dieudonne, B.; Vilar, J.; Faucounau, V.; Verny, M.; Neri, C.; Boulanger, C.M.; Boddaert, J. Biomarkers of vascular dysfunction and cognitive decline in patients with Alzheimer’s disease: No evidence for association in elderly subjects. Aging Clin. Exp. Res. 2016, 28, 1133–1141. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Moazzami, K.; Wittbrodt, M.T.; Lima, B.B.; Kim, J.H.; Hammadah, M.; Ko, Y.A.; Obideen, M.; Abdelhadi, N.; Kaseer, B.; Gafeer, M.M.; et al. Circulating Progenitor Cells and Cognitive Impairment in Men and Women with Coronary Artery Disease. J. Alzheimers Dis. 2020, 74, 659–668. [Google Scholar] [CrossRef] [PubMed]
- Liu, X.; Xie, C. Human endothelial progenitor cells isolated from COPD patients are dysfunctional. Mol. Cell Biochem. 2012, 363, 53–63. [Google Scholar] [CrossRef] [PubMed]
- Palange, P.; Testa, U.; Huertas, A.; Calabro, L.; Antonucci, R.; Petrucci, E.; Pelosi, E.; Pasquini, L.; Satta, A.; Morici, G.; et al. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur. Respir. J. 2006, 27, 529–541. [Google Scholar] [CrossRef]
- Gunawardene, P.; Al Saedi, A.; Singh, L.; Bermeo, S.; Vogrin, S.; Phu, S.; Suriyaarachchi, P.; Pignolo, R.J.; Duque, G. Age, gender, and percentage of circulating osteoprogenitor (COP) cells: The COP Study. Exp. Gerontol. 2017, 96, 68–72. [Google Scholar] [CrossRef]
- Grasselli, C.; Bombelli, S.; Eriani, S.; Domenici, G.; Galluccio, R.; Tropeano, C.; De Marco, S.; Bolognesi, M.M.; Torsello, B.; Bianchi, C.; et al. DNA Damage in Circulating Hematopoietic Progenitor Stem Cells as Promising Biological Sensor of Frailty. J. Gerontol. A Biol. Sci. Med. Sci. 2022, 77, 1279–1286. [Google Scholar] [CrossRef] [PubMed]
- Bonora, B.M.; Palano, M.T.; Testa, G.; Fadini, G.P.; Sangalli, E.; Madotto, F.; Persico, G.; Casciaro, F.; Vono, R.; Colpani, O.; et al. Hematopoietic progenitor cell liabilities and alarmins S100A8/A9-related inflammaging associate with frailty and predict poor cardiovascular outcomes in older adults. Aging Cell 2022, 21, e13545. [Google Scholar] [CrossRef] [PubMed]
- Quach, J.; Theou, O.; Perez-Zepeda, M.U.; Godin, J.; Rockwood, K.; Kehler, D.S. Effect of a physical activity intervention and frailty on frailty trajectory and major mobility disability. J. Am. Geriatr. Soc. 2022, 70, 2915–2924. [Google Scholar] [CrossRef] [PubMed]
- Suikkanen, S.; Soukkio, P.; Aartolahti, E.; Kaaria, S.; Kautiainen, H.; Hupli, M.T.; Pitkala, K.; Sipila, S.; Kukkonen-Harjula, K. Effect of 12-Month Supervised, Home-Based Physical Exercise on Functioning among Persons with Signs of Frailty: A Randomized Controlled Trial. Arch. Phys. Med. Rehabil. 2021, 102, 2283–2290. [Google Scholar] [CrossRef]
- Kao, C.H.; Chiang, S.L.; Chou, L.W.; Lin, C.H.; Lu, Y.H.; Lu, L.H.; Wang, X.M.; Lin, C.H. Validation of Vibration Exercises on Enhancing Muscle Strength and Upper Limb Functionality among Pre-Frail Community-Dwelling Older Adults. Int. J. Environ. Res. Public Health 2022, 19, 4509. [Google Scholar] [CrossRef]
- Liu, T.; Wang, C.; Sun, J.; Chen, W.; Meng, L.; Li, J.; Cao, M.; Liu, Q.; Chen, C. The Effects of an Integrated Exercise Intervention on the Attenuation of Frailty in Elderly Nursing Homes: A Cluster Randomized Controlled Trial. J. Nutr. Health Aging 2022, 26, 222–229. [Google Scholar] [CrossRef]
- Beigiene, A.; Petruseviciene, D.; Barasaite, V.; Kubilius, R.; Macijauskiene, J. Frailty and Different Exercise Interventions to Improve Gait Speed in Older Adults after Acute Coronary Syndrome. Medicina 2021, 57, 1344. [Google Scholar] [CrossRef]
- Suikkanen, S.; Soukkio, P.; Kautiainen, H.; Kaaria, S.; Hupli, M.T.; Sipila, S.; Pitkala, K.; Aartolahti, E.; Kukkonen-Harjula, K. Changes in the Severity of Frailty among Older Adults after 12 Months of Supervised Home-Based Physical Exercise: A Randomized Clinical Trial. J. Am. Med. Dir. Assoc. 2022, 23, 1717e9–1717e15. [Google Scholar] [CrossRef]
- Chen, J.; Gu, S.; Song, Y.; Ji, X.; Zeng, W.; Wang, X.; Wang, Y.; Feng, Q. The impact of cardiomotor rehabilitation on endothelial function in elderly patients with chronic heart failure. BMC Cardiovasc. Disord. 2021, 21, 524. [Google Scholar] [CrossRef]
- Yoshida, T.; Tabony, A.M.; Galvez, S.; Mitch, W.E.; Higashi, Y.; Sukhanov, S.; Delafontaine, P. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: Potential therapeutic targets for cardiac cachexia. Int. J. Biochem. Cell Biol. 2013, 45, 2322–2332. [Google Scholar] [CrossRef] [Green Version]
- Onder, G.; Penninx, B.W.; Balkrishnan, R.; Fried, L.P.; Chaves, P.H.; Williamson, J.; Carter, C.; Di Bari, M.; Guralnik, J.M.; Pahor, M. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: An observational study. Lancet 2002, 359, 926–930. [Google Scholar] [CrossRef] [PubMed]
- Cacciatore, F.; Bruzzese, G.; Vitale, D.F.; Liguori, A.; de Nigris, F.; Fiorito, C.; Infante, T.; Donatelli, F.; Minucci, P.B.; Ignarro, L.J.; et al. Effects of ACE inhibition on circulating endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive patients. Eur. J. Clin. Pharmacol. 2011, 67, 877–883. [Google Scholar] [CrossRef] [PubMed]
- Caulfield, L.; Heslop, P.; Walesby, K.E.; Sumukadas, D.; Sayer, A.A.; Witham, M.D. Effect of Angiotensin System Inhibitors on Physical Performance in Older People—A Systematic Review and Meta-Analysis. J. Am. Med. Dir. Assoc. 2021, 22, 1215.e2–1221.e2. [Google Scholar] [CrossRef] [PubMed]
- LACE Study Group; Achison, M.; Adamson, S.; Akpan, A.; Aspray, T.; Avenell, A.; Band, M.M.; Bashir, T.; Burton, L.A.; Cvoro, V.; et al. Effect of perindopril or leucine on physical performance in older people with sarcopenia: The LACE randomized controlled trial. J. Cachexia Sarcopenia Muscle 2022, 13, 858–871. [Google Scholar] [PubMed]
- Butt, J.H.; Jhund, P.S.; Belohlavek, J.; de Boer, R.A.; Chiang, C.E.; Desai, A.S.; Drozdz, J.; Hernandez, A.F.; Inzucchi, S.E.; Katova, T.; et al. Efficacy and Safety of Dapagliflozin According to Frailty in Patients with Heart Failure: A Prespecified Analysis of the DELIVER Trial. Circulation 2022, 146, 1210–1224. [Google Scholar] [CrossRef] [PubMed]
- Bonora, B.M.; Cappellari, R.; Albiero, M.; Avogaro, A.; Fadini, G.P. Effects of SGLT2 Inhibitors on Circulating Stem and Progenitor Cells in Patients With Type 2 Diabetes. J. Clin. Endocrinol. Metab. 2018, 103, 3773–3782. [Google Scholar] [CrossRef] [Green Version]
- Nandula, S.R.; Kundu, N.; Awal, H.B.; Brichacek, B.; Fakhri, M.; Aimalla, N.; Elzarki, A.; Amdur, R.L.; Sen, S. Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes. Cardiovasc. Diabetol. 2021, 20, 44. [Google Scholar] [CrossRef]
- Mone, P.; Varzideh, F.; Jankauskas, S.S.; Pansini, A.; Lombardi, A.; Frullone, S.; Santulli, G. SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights from Frail Hypertensive and Diabetic Patients. Hypertension 2022, 79, 1633–1643. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Komici, K.; Perna, A.; Guerra, G. Role of Endothelial Progenitor Cells in Frailty. Int. J. Mol. Sci. 2023, 24, 2139. https://doi.org/10.3390/ijms24032139
Komici K, Perna A, Guerra G. Role of Endothelial Progenitor Cells in Frailty. International Journal of Molecular Sciences. 2023; 24(3):2139. https://doi.org/10.3390/ijms24032139
Chicago/Turabian StyleKomici, Klara, Angelica Perna, and Germano Guerra. 2023. "Role of Endothelial Progenitor Cells in Frailty" International Journal of Molecular Sciences 24, no. 3: 2139. https://doi.org/10.3390/ijms24032139